Enzalutamide More Effective than Bicalutamide in mCRPC Patients

Enzalutamide More Effective than Bicalutamide in mCRPC Patients

Bicalutamide is a non-steroidal oral anti-androgen that is approved for use in conjunction with luteinizing hormone-releasing hormone (LHRH) analogues in men with hormone-treatment naïve prostate cancer. “Despite the widespread use of bicalutamide, …

(Visited 2 times, 1 visits today)
2
Like
Save

Comments

Comments are disabled for this post.